Article Text

PDF
Capla and the treatment of hypertension

Abstract

Wallace Laboratories have recently introduced a number of preparations in Britain which have for some time been available in the U. S. (see MIMS, January, 1964). Mebutamate (Capla - Wallace) is one of these. It is closely related to meprobamate, and is intended for the treatment of mild hypertension. It has not however been shown that the use of any hypotensive drug improves the prognosis in mild hypertension.

Statistics from Altmetric.com

Footnotes

  • * Based on material published on January 31, 1964 in The Medical Letter, New York.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.